Sahara India Medical Institute Profile
Key Indicators
- Authorised Capital ₹ 150.00 Cr
as on 02-11-2024
- Paid Up Capital ₹ 150.00 Cr
as on 02-11-2024
- Company Age 27 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 640.00 Cr
as on 02-11-2024
- Revenue 5.48%
(FY 2023)
- Profit -37.78%
(FY 2023)
- Ebitda 11.04%
(FY 2023)
- Net Worth 7.35%
(FY 2023)
- Total Assets 3.36%
(FY 2023)
About Sahara India Medical Institute
- CIN/LLPIN
U85110MH1997PLC109186
- Company No.
109186
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Jul 1997
- Date of AGM
26 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sahara India Medical Institute?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anupam Srivastava | Company Secretary | 11-Jun-2019 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harindra Kumar | Director | 02-Dec-2004 | Current |
Vijay Pandey | Director | 25-Feb-2023 | Current |
Bibek Chowdhary | Director | 27-Apr-2023 | Current |
Shelly Sharma | Director | 30-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Sahara India Medical Institute.
Sahara India Medical Institute Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.48% increase. The company also saw a substantial fall in profitability, with a 37.78% decrease in profit. The company's net worth moved up by a moderate rise of 7.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sahara India Medical Institute?
In 2023, Sahara India Medical Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sahara One Media And Entertainment LimitedActive 43 years 4 months
Bibek Chowdhary is a mutual person
- Chaalaka Development And Reality Private LimitedActive 27 years 11 days
Harindra Kumar is a mutual person
- Sahara India Management And Maintenance CorporationActive 33 years 4 months
Vijay Pandey is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 07 Sep 2017 | ₹500.00 Cr | Satisfied |
Union Bank Of India Creation Date: 02 Aug 2007 | ₹25.00 Cr | Satisfied |
Canara Bank Creation Date: 17 May 2007 | ₹25.00 Cr | Satisfied |
How Many Employees Work at Sahara India Medical Institute?
Sahara India Medical Institute has a workforce of 693 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahara India Medical Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahara India Medical Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.